Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: A cross sectional study

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Farid, Mohammad Ali Kashani ^a   Azizi, Fereidoun ^b   Hedayati, Mehdi ^b   Daneshpour, Maryam S ^c   Shamshiri, Ahmad Reza ^a   Siassi, Fereydoun ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; DNA MODIFICATION METHYLASE TAQI; LIPH PROTEIN, HUMAN; SITE SPECIFIC DNA METHYLTRANSFERASE (ADENINE SPECIFIC); TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; BLOOD; DYSLIPIDEMIA; GENETICS; IRAN; METABOLISM; MIDDLE AGED; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; IRAN; LIPASE; LIPIDS; MALE; MALONDIALDEHYDE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC); VASCULAR DISEASES;

EID: 77957166051     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-96     Document Type: Article

References (47)

1. The Atlas of Heart Disease and Stroke (World Health Organization, Geneva). J Mackay GA Mensah, 2004
2. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. K Kuulasmaa H Tunstall-Pedoe A Dobson S Fortmann S Sans H Tolonen A Evans M Ferrario J Tuomilehto, Lancet 2000 355 675 687 10.1016/S0140-6736(99)11180-2 10703799
3. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. R Clarke JR Emberson S Parish A Palmer M Shipley P Linksted P Sherliker S Clark J Armitage A Fletcher R Collins, Arch Intern Med 2007 167 1373 1378 10.1001/archinte.167.13.1373 17620530
4. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. MJ Chapman G Assmann JC Fruchart J Shepherd C Sirtori, Curr Med Res Opin 2004 20 1253 1268 10.1185/ 030079904125004402 15324528
5. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. MJAG Chapman JC Fruchart J Shepherd C Sirtori, Curr Med Res Opin 2004 20 8 1253 1268 10.1185/030079904125004402 15324528
6. High-density lipoprotein - the clinical implications of recent studies. DJRB Gordon, N Engl J Med 1989 321 19 1311 1316 10.1056/NEJM198911093211907 2677733
7. Effects of the amount and intensity of exercise on plasma lipoproteins. WE Kraus JA Houmard BD Duscha KJ Knetzger MB Wharton JS McCartney CW Bales S Henes GP Samsa JD Otvos, et al. N Engl J Med 2002 347 1483 1492 10.1056/NEJMoa020194 12421890
8. Heritability of cardiovascular and personality traits in 6,148 Sardinians. G Pilia WM Chen A Scuteri M Orru G Albai M Dei S Lai G Usala M Lai P Loi, et al. PLoS Genet 2006 2 132 10.1371/journal.pgen.0020132 16934002
9. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. CJ Willer S Sanna AU Jackson A Scuteri LL Bonnycastle R Clarke SC Heath NJ Timpson SS Najjar HM Stringham, et al. Nat Genet 2008 40 161 169 10.1038/ng.76 18193043
10. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. S Kathiresan O Melander C Guiducci A Surti NP Burtt MJ Rieder GM Cooper C Roos BF Voight AS Havulinna, et al. Nat Genet 2008 40 189 197 10.1038/ng.75 18193044
11. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. R Guerra J Wang SM Grundy JC Cohen, Proc Natl Acad Sci USA 1997 94 4532 4537 10.1073/pnas.94.9.4532 9114024
12. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. JC Cohen Z Wang SM Grundy MR Stoesz R Guerra, J Clin Invest 1994 94 2377 2384 10.1172/JCI117603 7989594
13. Plasma cholesteryl ester transfer protein. AR Tall, J Lipid Res 1993 34 1255 1274 8409761
14. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. PJ Barter HB Brewer MJ Chapman CH Hennekens DJ Rader AR Tall, Arterioscler Thromb Vasc Biol 2003 23 160 167 10.1161/01.ATV. 0000054658.91146.64 12588754
15. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. D Drayna R Lawn, Nucleic Acids Res 1987 15 4698 10.1093/nar/15.11.4698 2884631
16. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. ML Hannuksela MJ Liinamaa YA Kesaniemi MJ Savolainen, Atherosclerosis 1994 110 35 44 10.1016/0021-9150(94)90065-5 7857368
17. The -514 C- > T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. A Isaacs FA Sayed-Tabatabaei OT Njajou JC Witteman CM van Duijn, J Clin Endocrinol Metab 2004 89 3858 3863 10.1210/jc.2004-0188 15292318
18. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. SH Juo Z Han JD Smith L Colangelo K Liu, J Lipid Res 2001 42 258 264 11181756
19. The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. WJ Johnson MJ Bamberger RA Latta PE Rapp MC Phillips GH Rothblat, J Biol Chem 1986 261 5766 5776 3700371
20. Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester. H Kadowaki GM Patton SJ Robins, J Lipid Res 1992 33 1689 1698 1464752
21. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII: B: European Atherosclerosis Research Study (EARS) II. H Jansen G Chu C Ehnholm J Dallongeville V Nicaud PJ Talmud, Arterioscler Thromb Vasc Biol 1999 19 303 308 9974411
22. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. H Jansen AJ Verhoeven L Weeks JJ Kastelein DJ Halley A van den Ouweland JW Jukema JC Seidell JC Birkenhager, Arterioscler Thromb Vasc Biol 1997 17 2837 2842 9409263
23. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. P Couture JD Otvos LA Cupples C Lahoz PW Wilson EJ Schaefer JM Ordovas, Arterioscler Thromb Vasc Biol 2000 20 815 822 10712408
24. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. JM Ordovas D Corella S Demissie LA Cupples P Couture O Coltell PW Wilson EJ Schaefer KL Tucker, Circulation 2002 106 2315 2321 10.1161/01.CIR.0000036597. 52291.C9 12403660
25. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. YL Ko LA Hsu KH Hsu YH Ko YS Lee, Atherosclerosis 2004 172 135 142 10.1016/j.atherosclerosis.2003.09.013 14709367
26. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. E Tahvanainen M Syvanne MH Frick S Murtomaki-Repo M Antikainen YA Kesaniemi H Kauma A Pasternak MR Taskinen C Ehnholm, J Clin Invest 1998 101 956 960 10.1172/JCI1144 9486964
27. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. MC Carr AF Ayyobi SJ Murdoch SS Deeb JD Brunzell, Arterioscler Thromb Vasc Biol 2002 22 667 673 10.1161/01.ATV.0000013284.47317.95 11950708
28. Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population. DZ Fang BW Liu, Atherosclerosis 2002 161 417 424 10.1016/S0021-9150(01)00652-9 11888526
29. Visceral obesity attenuates the effect of the hepatic lipase -514C > T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. J St-Pierre I Miller-Felix ME Paradis J Bergeron B Lamarche JP Despres D Gaudet MC Vohl, Mol Genet Metab 2003 78 31 36 10.1016/S1096-7192(02)00223-8 12559845
30. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). F Azizi M Rahmani H Emami P Mirmiran R Hajipour M Madjid J Ghanbili A Ghanbarian Y Mehrabi N Saadat, et al. Soz Praventivmed 2002 47 408 426 12643001
31. An accelerated nutrition transition in Iran. H Ghassemi G Harrison K Mohammad, Public Health Nutr 2002 5 149 155 10.1079/PHN2001287 12027278
32. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. AR Sharrett CM Ballantyne SA Coady G Heiss PD Sorlie D Catellier W Patsch, Circulation 2001 104 1108 1113 10.1161/hc3501.095214 11535564
33. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. WP Castelli RJ Garrison PW Wilson RD Abbott S Kalousdian WB Kannel, JAMA 1986 256 2835 2838 10.1001/jama.256.20.2835 3773200
34. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. G Heiss I Tamir CE Davis HA Tyroler BM Rifkand G Schonfeld D Jacobs ID Frantz Jr, Circulation 1980 61 302 315 7351055
35. Tehran Lipid and Glucose Study, study methodology and summarized findings. F Azizi, Endocrine Research Center Publication, Tehran 2001
36. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. F Fumeron D Betoulle G Luc I Behague S Ricard O Poirier R Jemaa A Evans D Arveiler P Marques-Vidal, et al. J Clin Invest 1995 96 1664 1671 10.1172/JCI118207 7657837
37. Tehran Lipid and Glucose Study: rationale and design. F Azizi M Rahmani H Emami M Madjid, CVD Prev 2000 3 242 247
38. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 499 502 4337382
39. Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides. CR Wade AM van Rij, Life Sci 1988 43 1085 1093 10.1016/0024-3205(88)90204-4 3172976
40. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). GE Truett P Heeger RL Mynatt AA Truett JA Walker ML Warman, Biotechniques 2000 29 52 54 10907076
41. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. JM Ordovas LA Cupples D Corella JD Otvos D Osgood A Martinez C Lahoz O Coltell PW Wilson EJ Schaefer, Arterioscler Thromb Vasc Biol 2000 20 1323 1329 10807749
42. PowerMarker: an integrated analysis environment for genetic marker analysis. K Liu SV Muse, Bioinformatics 2005 21 2128 2129 10.1093/ bioinformatics/bti282 15705655
43. TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS). MS Daneshpour M Hedayati F Azizi, Genetics and Molecular Biology 2007 30 1039 1046 10.1590/S1415-47572007000600001
44. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. A Thompson E Di Angelantonio N Sarwar S Erqou D Saleheen RP Dullaart B Keavney Z Ye J Danesh, JAMA 2008 299 2777 2788 10.1001/jama.299.23.2777 18560005
45. Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. T Hassanzadeh M Firoozrai AE Zonouz A Zavarehee M Paoli, Indian J Med Res 2009 129 293 298 19491422
46. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. FM van't Hooft B Lundahl F Ragogna F Karpe G Olivecrona A Hamsten, Arterioscler Thromb Vasc Biol 2000 20 1335 1339 10807751
47. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. M Aviram M Rosenblat, Curr Opin Lipidol 2005 16 393 399 10.1097/01.mol.0000174398.84185.0f 15990587